Patent Assignment
Reel/Frame 055358/0400
Assignment of Assignor's Interest
Recorded: 2021-02-22
Pages: 4
Assignor
CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
Executed: 2020-12-18
Assignee
RESVERLOGIX CORP.
300, 4820 RICHARD ROAD SW, CALGARY, ALBERTA, T3E 6L1, CANADA
Covered Property
(1)
Crystalline Forms of a Bromodomain and Extraterminal Protein Inhibitor Drug, Processes for Preparation Thereof, and Use Thereof
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2019
From: CHEN, MINHUA; ZHANG, YANFENG; ZHAI, XIAOTING; YAN, KAIQIANG
To: CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
Reel/Frame 049406/0798 →
Security Interest
Jan 14, 2022
From: RESVERLOGIX CORP.
To: HEPALINK (HONG KONG) LIMITED
Reel/Frame 058655/0643 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 058655 Frame 0643. Assignor(S) Hereby Confirms the Security Interest.
Jan 27, 2022
From: RESVERLOGIX CORP.
To: HEPALINK (HONG KONG) LIMITED
Reel/Frame 058887/0288 →